DNA vs. QSI
DNA (Ginkgo Bioworks Holdings, Inc.) and QSI (Quantum-Si incorporated) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, DNA returned -53.04%/yr vs -40.85%/yr for QSI. At a 0.50 correlation, their price movements are largely independent.
Performance
DNA vs. QSI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DNA achieves a 8.90% return, which is significantly higher than QSI's -20.97% return.
DNA
- 1D
- -0.44%
- 1M
- 14.70%
- 6M
- -5.33%
- YTD
- 8.90%
- 1Y
- -9.32%
- 3Y*
- -51.95%
- 5Y*
- -53.04%
- 10Y*
- —
QSI
- 1D
- -1.52%
- 1M
- -8.18%
- 6M
- -28.16%
- YTD
- -20.97%
- 1Y
- -49.75%
- 3Y*
- -28.91%
- 5Y*
- -40.85%
- 10Y*
- —
DNA vs. QSI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
DNA Ginkgo Bioworks Holdings, Inc. | 8.90% | -15.38% | -85.47% | 0.00% | -79.66% | -16.06% |
QSI Quantum-Si incorporated | -20.97% | -59.26% | 34.33% | 9.84% | -76.75% | -25.40% |
Correlation
The correlation between DNA and QSI is 0.52, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.52 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.51 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.50 |
Correlation (All Time) Calculated using the full available price history since Jun 10, 2021 | 0.50 |
The correlation between DNA and QSI has been stable across timeframes, ranging from 0.50 to 0.52 - a consistent structural relationship.
Fundamentals
DNA:
$591.19M
QSI:
$171.97M
DNA:
-$5.35
QSI:
-$0.50
DNA:
4.23
QSI:
97.52
DNA:
1.22
QSI:
0.94
DNA:
$121.84M
QSI:
$1.85M
DNA:
$99.27M
QSI:
-$3.71M
DNA:
-$218.90M
QSI:
-$104.05M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DNA vs. QSI — Risk / Return Rank
DNA
QSI
DNA vs. QSI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ginkgo Bioworks Holdings, Inc. (DNA) and Quantum-Si incorporated (QSI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DNA | QSI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.45 | ||
| Sortino ratioReturn per unit of downside risk | +1.05 | ||
| Omega ratioGain probability vs. loss probability | 1.07 | 0.95 | +0.12 |
| Calmar ratioReturn relative to maximum drawdown | -0.14 | -0.68 | +0.54 |
| Martin ratioReturn relative to average drawdown | -0.23 | -0.96 | +0.73 |
Loading charts...
Drawdowns
DNA vs. QSI - Drawdown Comparison
The maximum DNA drawdown since its inception was -99.10%, roughly equal to the maximum QSI drawdown of -95.33%. Use the drawdown chart below to compare losses from any high point for DNA and QSI.
Loading charts...
Drawdown Indicators
| DNA | QSI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.10% | -95.33% | -3.77% |
Max Drawdown (1Y)Largest decline over 1 year | -66.05% | -72.95% | +6.90% |
Max Drawdown (3Y)Largest decline over 3 years | -94.72% | -83.73% | -10.99% |
Max Drawdown (5Y)Largest decline over 5 years | -99.10% | -95.02% | -4.08% |
Current DrawdownCurrent decline from peak | -98.48% | -93.59% | -4.89% |
Average DrawdownAverage peak-to-trough decline | -80.14% | -79.47% | -0.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 40.55% | 51.73% | -11.18% |
Volatility
DNA vs. QSI - Volatility Comparison
Ginkgo Bioworks Holdings, Inc. (DNA) has a higher volatility of 21.01% compared to Quantum-Si incorporated (QSI) at 19.73%. This indicates that DNA's price experiences larger fluctuations and is considered to be riskier than QSI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DNA | QSI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.01% | 19.73% | +1.28% |
Volatility (6M)Calculated over the trailing 6-month period | 71.66% | 61.58% | +10.08% |
Volatility (1Y)Calculated over the trailing 1-year period | 95.74% | 91.92% | +3.82% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 98.31% | 125.07% | -26.76% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 96.07% | 124.73% | -28.66% |
Dividends
DNA vs. QSI - Dividend Comparison
Neither DNA nor QSI has paid dividends to shareholders.
Financials
DNA vs. QSI - Financials Comparison
This section allows you to compare key financial metrics between Ginkgo Bioworks Holdings, Inc. and Quantum-Si incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
DNA and QSI have a correlation of 0.52, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DNA has higher volatility (21.01%) compared to QSI (19.73%). In terms of maximum drawdown, DNA dropped -99.10% vs QSI's -95.33%.
DNA currently has the higher Sharpe Ratio (-0.10 vs -0.54), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DNA and QSI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer